Angiographic Injection System, Model R2000-CMS
by ACIST Medical Systems, Inc.
510(k) K010390
Active
Valid until
No expiry
FDA recalls
None ongoingDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK010390 | Date9 Mar 2001 | StatusActive |
Recalls
-
- Terminated Z-0643-2009
Multiple Injections may result. It has been determined that when using the ACIST CVi Angiographic Injection system to synchronize with the Toshiba Infinix -i cardiovascular x-ray system there is an injection scenario that may result in multiple injections of contract media when one injection was intended.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- Full name
- Acist Angiographic Injection System, Model R2000-Cms
- 510(k) Number
- FDA product code
- DXT
- Device class
- Class II
- Regulation
- 21 CFR Part 870.1650
- Advisory committee
- Cardiovascular
- FDA decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 18 Sep 2026
The Angiographic Injection System, Model R2000-CMS, is an Injector and Syringe, Angiographic (OpenFDA classification: Device Class II). It is designed to deliver contrast media during angiographic procedures, facilitating the visualization of blood vessels for diagnostic and interventional cardiovascular assessments.
This system is intended for use in clinical settings, typically within cardiac catheterization labs. It operates as a reusable device, requiring appropriate sterilization and maintenance protocols. The Model R2000-CMS holds FDA 510(k) clearance (K010390) under the Cardiovascular advisory committee review, with a Special 510(k) classification. No MRI safety or single-use specifications are indicated in the regulatory data.
From the manufacturer
ACIST Medical Systems provides innovative contrast injector & IVUS catheter diagnostic technologies to visualize, assess & improve patient treatment.